(Q35637982)

9 August 2017

1 reference

title

Beta-blocker underuse in secondary prevention of myocardial infarction (English)

1 reference

9 August 2017

Matthew J Everly

1

1 reference

9 August 2017

Pamela C Heaton

series ordinal

2

1 reference

9 August 2017

Robert J Cluxton

series ordinal

3

1 reference

9 August 2017

language of work or name

English

0 references

publication date

30 December 2003

1 reference

Annals of Pharmacotherapy

9 August 2017

published in

1 reference

9 August 2017

volume

38

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

286-293

1 reference

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

9 August 2017

cites work

1 reference

Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction

21 January 2018

1 reference

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial

21 January 2018

1 reference

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.

21 January 2018

1 reference

21 January 2018

1 reference

Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project

21 January 2018

1 reference

Contemporary management of acute myocardial infarction.

21 January 2018

1 reference

National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.

21 January 2018

1 reference

Secondary prevention after high-risk acute myocardial infarction with low-dose acebutolol.

21 January 2018

1 reference

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

21 January 2018

1 reference

Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials

21 January 2018

1 reference

Physical inactivity as a risk factor for primary and secondary coronary events in Göteborg, Sweden

21 January 2018

1 reference

Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice

21 January 2018

1 reference

21 January 2018

1 reference

How should age affect management of acute myocardial infarction? A prospective cohort study

21 January 2018

1 reference

Diabetic patients and beta-blockers after acute myocardial infarction

21 January 2018

1 reference

Beta-blockers and sudden cardiac death.

21 January 2018

1 reference

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

21 January 2018

1 reference

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

21 January 2018

1 reference

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study

21 January 2018

1 reference

Chronic effects of labetalol, pindolol, and propranolol on calf blood flow in intermittent claudication.

21 January 2018

1 reference

Intermittent claudication complicating beta-blockade

21 January 2018

1 reference

The effect of withdrawal of beta-adrenergic blockade on intermittent claudication

21 January 2018

1 reference

Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1C472

1 reference

9 August 2017

1 reference